Patents by Inventor Bruno C. Hancock

Bruno C. Hancock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immediate release dosage forms containing solid drug dispersions
    Patent number: 9211261
    Abstract: High loading immediate release dosage forms containing at least 30 wt % of a solid drug dispersion, at least 5 wt % of a disintegrant and a porosigen are disclosed that exhibit excellent strength and aqueous solubility.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: December 15, 2015
    Assignee: Bend Research, Inc.
    Inventors: Leah E. Appel, John E. Byers, Marshall D. Crew, Dwayne T. Friesen, Bruno C. Hancock, Stephen J. Schadtle
  • Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor
    Patent number: 7897175
    Abstract: A dosage form comprises (1) a solid amorphous dispersion comprising a cholesterol ester transfer protein inhibitor and an acidic concentration-enhancing polymer and (2) an HMG-CoA reductase inhibitor. The solid amorphous dispersion and the HMG-CoA reductase inhibitor are combined in the dosage form so that the solid amorphous dispersion and the HMG-CoA reductase inhibitor are substantially separate from one another in the dosage form.
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: March 1, 2011
    Assignee: Bend Research, Inc.
    Inventors: Dwayne T. Friesen, David K. Lyon, Douglas A. Lorenz, Bruno C. Hancock, Timothy J. McDermott, Ravi M. Shanker
  • IMMEDIATE RELEASE DOSAGE FORMS CONTAINING SOLID DRUG DISBURSIONS
    Publication number: 20080317851
    Abstract: High loading immediate release dosage forms containing at least 30 wt % of a solid drug dispersion, at least 5 wt % of a disintegrant and a porosigen are disclosed that exhibit excellent strength and aqueous solubility.
    Type: Application
    Filed: October 30, 2007
    Publication date: December 25, 2008
    Inventors: Leah E. Appel, John E. Byers, Marshall D. Crew, Dwayne T. Friesen, Bruno C. Hancock, Stephen J. Schadtle
  • Pharmaceutical compositions of a sparingly soluble glycogen phosphorylase inhibitor
    Patent number: 7235260
    Abstract: Pharmaceutical compositions of a particularly effective sparingly soluble glycogen phosphorylase inhibitor are disclosed, as well as methods of making such compositions and dosage forms from such compositions.
    Type: Grant
    Filed: March 21, 2003
    Date of Patent: June 26, 2007
    Assignee: Pfizer Inc
    Inventors: Marshall D. Crew, Dwayne T. Friesen, Bruno C. Hancock, Chris Macri, James A. S. Nightingale, Ravi M. Shankar
  • Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor
    Publication number: 20040197398
    Abstract: A dosage form comprises (1) a solid amorphous dispersion comprising a cholesterol ester transfer protein inhibitor and an acidic concentration-enhancing polymer and (2) an HMG-CoA reductase inhibitor. The solid amorphous dispersion and the HMG-CoA reductase inhibitor are combined in the dosage form so that the solid amorphous dispersion and the HMG-CoA reductase inhibitor are substantially separate from one another in the dosage form.
    Type: Application
    Filed: December 18, 2003
    Publication date: October 7, 2004
    Applicant: Pfizer Inc.
    Inventors: Dwayne T. Friesen, David K. Lyon, Douglas A. Lorenz, Bruno C. Hancock, Timothy J. McDermott, Ravi M. Shanker
  • Dosage forms comprising a CETP inhibitor and an HMG-CoA reductase inhibitor
    Publication number: 20040185102
    Abstract: A dosage form comprises (1) a solid amorphous dispersion comprising a cholesteryl ester transfer protein inhibitor and a neutral or neutralized acidic polymer and (2) an HMG-CoA reductase inhibitor. The dosage form provides improved chemical stability of the HMG-CoA reductase inhibitor.
    Type: Application
    Filed: December 18, 2003
    Publication date: September 23, 2004
    Applicant: Pfizer Inc
    Inventors: Dwayne T. Friesen, David K. Lyon, Douglas A. Lorenz, Rodney J. Ketner, Bruno C. Hancock, Timothy J. McDermott, Ravi M. Shanker
  • Immediate release dosage forms containing solid drug dispersions
    Publication number: 20030224043
    Abstract: High loading immediate release dosage forms containing at least 30 wt % of a solid drug dispersion, at least 5 wt % of a disintegrant and a porosigen are disclosed that exhibit excellent strength and aqueous solubility.
    Type: Application
    Filed: January 31, 2003
    Publication date: December 4, 2003
    Applicant: Pfizer Inc.
    Inventors: Leah E. Appel, John E. Byers, Marshall D. Crew, Dwayne T. Friesen, Bruno C. Hancock, Stephen J. Schadtle
  • Glycogen phosphorylase inhibitor
    Publication number: 20030185891
    Abstract: Pharmaceutical compositions of a particularly effective sparingly soluble glycogen phosphorylase inhibitor are disclosed, as well as methods of making such compositions and dosage forms from such compositions.
    Type: Application
    Filed: March 21, 2003
    Publication date: October 2, 2003
    Applicant: Pfizer Inc.
    Inventors: Marshall D. Crew, Dwayne T. Friesen, Bruno C. Hancock, Chris Macri, James A.S. Nightingale, Ravi M. Shanker
  • Glycogen phosphorylase inhibitor
    Publication number: 20010053791
    Abstract: Pharmaceutical compositions of a particularly effective sparingly soluble glycogen phosphorylase inhibitor are disclosed, as well as methods of making such compositions and dosage forms from such compositions.
    Type: Application
    Filed: March 14, 2001
    Publication date: December 20, 2001
    Inventors: Walter C. Babcock, Marshall D. Crew, Dwayne T. Friesen, Bruno C. Hancock, Douglas A. Lorenz, Chris Macri, James A.S. Nightingale, Ravi M. Shanker